phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Arterial Occlusive Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borm, A; Hirsh, J; Klement, P; Maraganore, J; Weitz, J; Wilson, G | 1 |
1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Arterial Occlusive Diseases
| Article | Year |
|---|---|
The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Animals; Arterial Occlusive Diseases; Disease Models, Animal; Heparin; Hirudin Therapy; Male; Molecular Sequence Data; Partial Thromboplastin Time; Peptides; Rats; Rats, Inbred Strains; Regional Blood Flow; Thrombin; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1992 |